Literature DB >> 12672049

The neutrophil-activating protein of Helicobacter pylori (HP-NAP) activates the MAPK pathway in human neutrophils.

Hiroaki Nishioka1, Ilenia Baesso, Gianpietro Semenzato, Livio Trentin, Rino Rappuoli, Giuseppe Del Giudice, Cesare Montecucco.   

Abstract

Infection by Helicobacter pylori causes an acute inflammatory response followed by a chronic infection of the human gastric mucosa characterized by the infiltration of neutrophils andmononuclear inflammatory cells. The neutrophil-activating protein of Helicobacter pylori (HP-NAP) is a virulence factor that activates neutrophils, monocytes, and mast cells. However, the mechanism by which HP-NAP activates these cells is not fully understood. Here, we show that HP-NAP induces extracellular regulated kinase (ERK) and p38-mitogen-activated protein kinase (MAPK) activation in human neutrophils; c-Jun N-terminal kinase is not activated by HP-NAP. A MAPK/ERK kinase inhibitor and a p38-MAPK inhibitor suppress HP-NAP-mediated neutrophil oxidative burst, adhesion, andchemotaxis, but not actin polymerization. Pertussis toxin (PTX) inhibits all these neutrophil functions and the MAPK activation caused by HP-NAP. These results demonstrate that HP-NAP activates neutrophils through a PTX-sensitive pathway and that ERK and p38-MAPK are involved in many neutrophil functions stimulated by HP-NAP.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12672049     DOI: 10.1002/eji.200323726

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  18 in total

1.  Activation of the Raf-MEK-ERK pathway is required for neutrophil extracellular trap formation.

Authors:  Abdul Hakkim; Tobias A Fuchs; Nancy E Martinez; Simone Hess; Heino Prinz; Arturo Zychlinsky; Herbert Waldmann
Journal:  Nat Chem Biol       Date:  2010-12-19       Impact factor: 15.040

2.  Immunogenicity of attenuated measles virus engineered to express Helicobacter pylori neutrophil-activating protein.

Authors:  Ianko D Iankov; Iana H Haralambieva; Evanthia Galanis
Journal:  Vaccine       Date:  2010-12-21       Impact factor: 3.641

3.  Helicobacter pylori SabA adhesin evokes a strong inflammatory response in human neutrophils which is down-regulated by the neutrophil-activating protein.

Authors:  Christoffer Petersson; Maria Forsberg; Marina Aspholm; Farzad O Olfat; Tony Forslund; Thomas Borén; Karl-Eric Magnusson
Journal:  Med Microbiol Immunol       Date:  2006-06-07       Impact factor: 3.402

4.  Helicobacter pylori neutrophil activating protein as target for new drugs against H. pylori inflammation.

Authors:  Theodora Choli-Papadopoulou; Filippos Kottakis; Georgios Papadopoulos; Stefanos Pendas
Journal:  World J Gastroenterol       Date:  2011-06-07       Impact factor: 5.742

5.  Helicobacter pylori neutrophil-activating protein induces release of histamine and interleukin-6 through G protein-mediated MAPKs and PI3K/Akt pathways in HMC-1 cells.

Authors:  Chung-Che Tsai; Ting-Yu Kuo; Zhi-Wei Hong; Ying-Chieh Yeh; Kuo-Shun Shih; Shin-Yi Du; Hua-Wen Fu
Journal:  Virulence       Date:  2015-09-16       Impact factor: 5.882

6.  Dual Roles of Helicobacter pylori NapA in inducing and combating oxidative stress.

Authors:  Ge Wang; Yang Hong; Adriana Olczak; Susan E Maier; Robert J Maier
Journal:  Infect Immun       Date:  2006-10-09       Impact factor: 3.441

7.  Evaluation of the potential inhibitory activity of a combination of L. acidophilus, L. rhamnosus and L. sporogenes on Helicobacter pylori: A randomized double-blind placebo-controlled clinical trial.

Authors:  Chien-Ying Lee; Hung-Che Shih; Min-Chien Yu; Ming-Yung Lee; Ya-Lan Chang; Ya-Yun Lai; Yi-Ching Lee; Yu-Hsiang Kuan; Chun-Che Lin
Journal:  Chin J Integr Med       Date:  2016-10-19       Impact factor: 1.978

8.  Fusion expression of Helicobacter pylori neutrophil-activating protein in E.coli.

Authors:  Qiao-Zhen Kang; Guang-Cai Duan; Qing-Tang Fan; Yuan-Lin Xi
Journal:  World J Gastroenterol       Date:  2005-01-21       Impact factor: 5.742

9.  Construction of an oral recombinant DNA vaccine from H pylori neutrophil activating protein and its immunogenicity.

Authors:  Bo Sun; Zhao-Shen Li; Zhen-Xing Tu; Guo-Ming Xu; Yi-Qi Du
Journal:  World J Gastroenterol       Date:  2006-11-21       Impact factor: 5.742

10.  Detection and evaluation of antibodies against neutrophil-activating protein of Helicobacter pylori in patients with gastric cancer.

Authors:  Min Long; Jun Luo; Yan Li; Fang-Yin Zeng; Ming Li
Journal:  World J Gastroenterol       Date:  2009-05-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.